Detalhe da pesquisa
1.
A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes.
In Vivo
; 37(5): 2155-2160, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652493
2.
Therapeutic Efficacy of AFree Oral Spray on the Symptoms and Course of Moderate and Severe COVID-19 in the Field Hospital.
In Vivo
; 37(4): 1743-1750, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369463